Literature DB >> 33477721

The Biology of Vasopressin.

Samantha Sparapani1, Cassandra Millet-Boureima1, Joshua Oliver1, Kathy Mu1, Pegah Hadavi1, Tamar Kalostian1, Nazifa Ali1, Carla Maria Avelar1, Marion Bardies1, Brenton Barrow1, Minky Benedikt1, Giuliana Biancardi1, Raminder Bindra1, Lisa Bui1, Zakaria Chihab1, Ashley Cossitt1, Jeffrey Costa1, Tina Daigneault1, Jocelyn Dault1, Isa Davidson1, Jonathan Dias1, Emie Dufour1, Sabine El-Khoury1, Nargess Farhangdoost1, Anika Forget1, Alexa Fox1, Myriam Gebrael1, Maria Concetta Gentile1, Olivia Geraci1, Ansley Gnanapragasam1, Elias Gomah1, Elie Haber1, Claudia Hamel1, Thivya Iyanker1, Christina Kalantzis1, Sara Kamali1, Elsa Kassardjian1, Hryssi Krissy Kontos1, Thi Bich Uyen Le1, Daniella LoScerbo1, Yan Fang Low1, Danielle Mac Rae1, Flore Maurer1, Sana Mazhar1, Alice Nguyen1, Kathy Nguyen-Duong1, Chelsea Osborne-Laroche1, Hwi Wun Park1, Emilie Parolin1, Kahlila Paul-Cole1, Leah Sarah Peer1, Margaux Philippon1, Charles-Alexandre Plaisir1, Jessica Porras Marroquin1, Simran Prasad1, Rewaparsad Ramsarun1, Saad Razzaq1, Samantha Rhainds1, Damien Robin1, Ryan Scartozzi1, Davindra Singh1, Sajad Soleimani Fard1, Maxim Soroko1, Nastaran Soroori Motlagh1, Kiri Stern1, Laila Toro1, M Wyatt Toure1, Stephanie Tran-Huynh1, Sarah Trépanier-Chicoine1, Claudia Waddingham1, Aaliyah Jasmine Weekes1, Allison Wisniewski1, Chiara Gamberi1.   

Abstract

Vasopressins are evolutionarily conserved peptide hormones. Mammalian vasopressin functions systemically as an antidiuretic and regulator of blood and cardiac flow essential for adapting to terrestrial environments. Moreover, vasopressin acts centrally as a neurohormone involved in social and parental behavior and stress response. Vasopressin synthesis in several cell types, storage in intracellular vesicles, and release in response to physiological stimuli are highly regulated and mediated by three distinct G protein coupled receptors. Other receptors may bind or cross-bind vasopressin. Vasopressin is regulated spatially and temporally through transcriptional and post-transcriptional mechanisms, sex, tissue, and cell-specific receptor expression. Anomalies of vasopressin signaling have been observed in polycystic kidney disease, chronic heart failure, and neuropsychiatric conditions. Growing knowledge of the central biological roles of vasopressin has enabled pharmacological advances to treat these conditions by targeting defective systemic or central pathways utilizing specific agonists and antagonists.

Entities:  

Keywords:  GPCRs; cardiac function; renal function; sex differences; social behavior; vasopressin

Year:  2021        PMID: 33477721      PMCID: PMC7832310          DOI: 10.3390/biomedicines9010089

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  345 in total

1.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

2.  Sensitivity to intranasal oxytocin in adult men with early parental separation.

Authors:  Gunther Meinlschmidt; Christine Heim
Journal:  Biol Psychiatry       Date:  2006-12-04       Impact factor: 13.382

3.  Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.

Authors:  Daniel Huber; Pierre Veinante; Ron Stoop
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

4.  Regulation of poly(A) tail size of vasopressin mRNA.

Authors:  H H Zingg; D L Lefebvre; G Almazan
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

5.  Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug.

Authors:  E Meijer; R T Gansevoort; P E de Jong; A M van der Wal; W N Leonhard; S R de Krey; J van den Born; G M Mulder; H van Goor; J Struck; E de Heer; D J M Peters
Journal:  Nephrol Dial Transplant       Date:  2011-03-10       Impact factor: 5.992

6.  Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice.

Authors:  S R Wersinger; H K Caldwell; M Christiansen; W S Young
Journal:  Genes Brain Behav       Date:  2006-12-20       Impact factor: 3.449

Review 7.  Neuromodulation by oxytocin and vasopressin.

Authors:  Ron Stoop
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 8.  Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].

Authors:  Farhan Ali; M Adnan Raufi; Barbara Washington; Jalal K Ghali
Journal:  Cardiovasc Drug Rev       Date:  2007

Review 9.  The Oxytocin-Vasopressin Pathway in the Context of Love and Fear.

Authors:  C Sue Carter
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

Review 10.  Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.

Authors:  Mei-Yi Wu; Tzu-Ting Chen; Ying-Chun Chen; Der-Cherng Tarng; Yun-Chun Wu; Hsien-Ho Lin; Yu-Kang Tu
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

View more
  3 in total

1.  Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.

Authors:  Laine M Heidman; Nahuel Peinetti; Valeria A Copello; Kerry L Burnstein
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

2.  The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment.

Authors:  Bo Zhou; Xiaoli Zheng; Yunhua Chen; Xuehui Yan; Jinggang Peng; Yibu Liu; Yi Zhang; Lei Tang; Min Wen
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

3.  Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.

Authors:  Ming-Chun Chen; Yu-Chao Hsiao; Chun-Chun Chang; Sheng-Feng Pan; Chih-Wen Peng; Ya-Tzu Li; Cheng-Der Liu; Je-Wen Liou; Hao-Jen Hsu
Journal:  Biomedicines       Date:  2021-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.